1.Leiomyosarcoma of the Urinary Bladder.
Korean Journal of Urology 1972;13(1):81-83
Non-epithelial tumor of the urinary tract is very rare. We experienced a case of large leiomyosarcoma arising from the posterior wall of the urinary bladder in 49 year-old male.
Humans
;
Leiomyosarcoma*
;
Male
;
Middle Aged
;
Urinary Bladder*
;
Urinary Tract
2.Reimplantation of the Amputated Penis Using Microvascular Techniques.
Korean Journal of Urology 1980;21(4):395-398
Penile amputation is an unusual injury. There are several reports in the literature describing successful primary reanastomosis. We have an experience of a case of completely amputated penis that was reimplanted with the techniques of microvascular anastomosis of the dorsal arteries. The result was satisfactory for both urinary and sexual function. Herein we report this case with the review of the literatures.
Amputation
;
Arteries
;
Male
;
Microsurgery
;
Penis*
;
Replantation*
3.Clinical Study on the Renal Tuberculosis.
Korean Journal of Urology 1973;14(3):195-199
A clinical and statistical study was made on 34 cases of renal tuberculosis seen during the period from January, 1970 to August, 1972. The results are summarized as follows; l. The incidence of the renal tuberculosis is 1.2% of all urological patients. 2. Age and sex distribution show that 20 cases (58.8%) were male and I4 cases (4l.2%) were female, 14 cases (41. 2%) were in 30~39 years and 10 cases (29.4%) were in 20~29 years. 3. The initial symptoms were mostly those of vesical symptoms. frequency in 61.8%. hematuria in 32.4%, pain on urination in 23.5%. 4. 26.5% of the patients consulted within one year to five years after the onset of symptoms. 5. In 21 cases (6l.7%), had past history of tuberculous diseases or present other tuberculous 1esions, of which 52.4% had pulmonary tuberculosis, 23. 8% had tuberculous epididymitis. 6. 9 cases (25.5%) were affected in both sides, 14 cases were affected in right side and 11 cases were affected in left side. 7. The pyelogram showed that all kidneys were in far advanced. 8. Urinalysis revealed hematuria in 76.5%, pyuria in 73.5%, proteinuria in 67. 6% and tubercle bacilli were found by staining in 41. 2%. 9. Patients were treated with SM, INAH, and PAS. The patients who had an autonephrectomized kidney were treated by nephroureterectomy, in 2 cases of them sigmoidocystoplasty was performed.
Epididymitis
;
Female
;
Hematuria
;
Humans
;
Incidence
;
Kidney
;
Male
;
Proteinuria
;
Pyuria
;
Sex Distribution
;
Statistics as Topic
;
Tuberculosis, Pulmonary
;
Tuberculosis, Renal*
;
Urinalysis
;
Urination
4.Influence of Phentolamine on the centrally induced Renal effects of Norepinephrine and Dopamine in the Rabbit.
Korean Journal of Urology 1974;15(4):259-264
It has recently been reported that both norepinephrine and dopamine elicit antidiuresis when given intracerebroventricularly. But no inference has been made as to their mechanisms. As dopamine is the immediate precursor of norepinephrine in the biosynthesis of catecholamine, it might be possible that dopamine might act indirectly through increased level of norepinephrine in the brain tissue. To certify whether the dopamine-induced antidiuresis is related to norepinephrine, the influence of phentolamine, a specific alpha-adrenergic blocking agent, on the centrally induced antidiuresis of both norepinephrine and dopamine was investigated in this study. Norepinephrine and dopamine given intraventricularly elicited maximal antidiuresis in doses of 10ug and 500ug, respectively. Phentolamine, administered intravenously in dose of 2mg/kg, abolished the renal effect of norepinephrine given intraventricularly, but did not influence the antidiuresis induced by dopamine. It is suggested that both norepinephrine and dopamine produce antidiuresis when given intracerebroventricularly but their actions are mediated by different mechanisms, and that norepinephrine does not participate in the renal action of dopamine.
Brain
;
Dopamine*
;
Norepinephrine*
;
Phentolamine*
5.Application of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Imaging Mass Spectrometry (MALDI-TOF IMS) for Premalignant Gastrointestinal Lesions.
Kwang Hyun KO ; Chang Il KWON ; So Hye PARK ; Na Young HAN ; Hoo Keun LEE ; Eun Hee KIM ; Ki Baik HAHM
Clinical Endoscopy 2013;46(6):611-619
Imaging mass spectrometry (IMS) is currently receiving large attention from the mass spectrometric community, although its use is not yet well known in the clinic. As matrix-assisted laser desorption/ionization time-of-flight (MALDI)-IMS can show the biomolecular changes in cells as well as tissues, it can be an ideal tool for biomedical diagnostics as well as the molecular diagnosis of clinical specimens, especially aimed at the prompt detection of premalignant lesions much earlier before overt mass formation, or for obtaining histologic clues from endoscopic biopsy. Besides its use for pathologic diagnosis, MALDI-IMS is also a powerful tool for the detection and localization of drugs, proteins, and lipids in tissue. Measurement of parameters that define and control the implications, challenges, and opportunities associated with the application of IMS to biomedical tissue studies might be feasible through a deep understanding of mass spectrometry. In this focused review series, new insights into the molecular processes relevant to IMS as well as other field applications are introduced.
Biopsy
;
Chemoprevention
;
Diagnosis
;
Mass Spectrometry*
;
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
;
Biomarkers
6.Molecular Imaging for Theranostics in Gastroenterology: One Stone to Kill Two Birds.
Kwang Hyun KO ; Chang Il KOWN ; Jong Min PARK ; Hoo Geun LEE ; Na Young HAN ; Ki Baik HAHM
Clinical Endoscopy 2014;47(5):383-388
Molecular imaging in gastroenterology has become more feasible with recent advances in imaging technology, molecular genetics, and next-generation biochemistry, in addition to advances in endoscopic imaging techniques including magnified high-resolution endoscopy, narrow band imaging or autofluorescence imaging, flexible spectral imaging color enhancement, and confocal laser endomicroscopy. These developments have the potential to serve as "red flag" techniques enabling the earlier and accurate detection of mucosal abnormalities (such as precancerous lesions) beyond biomarkers, virtual histology of detected lesions, and molecular targeted therapy-the strategy of "one stone to kill two or three birds"; however, more effort should be done to be "blue ocean" benefit. This review deals with the introduction of Raman spectroscopy endoscopy, imaging mass spectroscopy, and nanomolecule development for theranostics. Imaging of molecular pathological changes in cells/tissues/organs might open the "royal road" to either convincing diagnosis of diseases that otherwise would only be detected in the advanced stages or novel therapeutic methods targeted to personalized medicine.
Biochemistry
;
Birds*
;
Diagnosis
;
Endoscopy
;
Gastroenterology*
;
Mass Spectrometry
;
Molecular Biology
;
Molecular Imaging*
;
Narrow Band Imaging
;
Optical Imaging
;
Spectrum Analysis, Raman
;
Biomarkers
;
Precision Medicine
7.Recent Advances in Molecular Imaging of Premalignant Gastrointestinal Lesions and Future Application for Early Detection of Barrett Esophagus.
Kwang Hyun KO ; Na Young HAN ; Chang Il KWON ; Hoo Keun LEE ; Jong Min PARK ; Eun Hee KIM ; Ki Baik HAHM
Clinical Endoscopy 2014;47(1):7-14
Recent advances in optical molecular imaging allow identification of morphologic and biochemical changes in tissues associated with gastrointestinal (GI) premalignant lesions earlier and in real-time. This focused review series introduces high-resolution imaging modalities that are being evaluated preclinically and clinically for the detection of early GI cancers, especially Barrett esophagus and esophageal adenocarcinoma. Although narrow band imaging, autofluorescence imaging, and chromoendoscopy are currently applied for this purpose in the clinic, further adoptions of probe-based confocal laser endomicroscopy, high-resolution microendoscopy, optical coherence tomography, and metabolomic imaging, as well as imaging mass spectrometry, will lead to detection at the earliest and will guide predictions of the clinical course in the near future in a manner that is beyond current advancements in optical imaging. In this review article, the readers will be introduced to sufficient information regarding this matter with which to enjoy this new era of high technology and to confront science in the field of molecular medical imaging.
Adenocarcinoma
;
Barrett Esophagus*
;
Diagnostic Imaging
;
Mass Spectrometry
;
Metabolomics
;
Molecular Imaging*
;
Narrow Band Imaging
;
Optical Imaging
;
Tomography, Optical Coherence
;
Biomarkers
8.Four trocar configurations for robot-assisted radical prostatectomy for da Vinci SP devices:Comparison of pros and cons and pricing
Young Hwii KO ; Byung Hoon KIM ; Sung Gu KANG ; Kwang Hyun KIM ; Jongsoo LEE ; Sung-Hoo HONG ; COSPUS (Consortium of Single Port Urologic Surgery)
Investigative and Clinical Urology 2024;65(3):311-314
9.Comparison of Rifabutin- and Levofloxacin-based Third-line Rescue Therapies for Helicobacter pylori.
Myung Ho JEONG ; Jun Won CHUNG ; Sang Jin LEE ; Minsu HA ; Seok Hoo JEONG ; Sunyoung NA ; Byung Soo NA ; Sung Keun PARK ; Yoon Jae KIM ; Kwang An KWON ; Kwang Il KO ; Yunjeong JO ; Ki Baik HAHM ; Hwoon Yong JUNG
The Korean Journal of Gastroenterology 2012;59(6):401-406
BACKGROUND/AIMS: There is increasing need for third-line therapy of Helicobacter pylori due to increasing level of antibiotics resistance. The aim of this study was to compare rifabutin and levofloxacin rescue regimens in patients with first- and second-line Helicobacter pylori eradication failures. METHODS: Patients, in whom a first treatment with proton pump inhibitor-clarithromycin-amoxicillin and a second trial with proton pump inhibitor-bismuth-tetracycline-metronidazole had failed, received treatment with either rifabutin or levofloxacin, plus amoxicillin (1 g twice daily) and standard dose proton pump inhibitor. Eradication rates were confirmed with 13C-urea breath test or rapid urease test 4 weeks after the cessation of therapy. RESULTS: Eradication rates were 71.4% in the rifabutin group, and 57.1% in the levofloxacin group, respectively. Although there was no significant difference in Helicobacter pylori eradication rates between two groups (p=0.656), rifabutin based regimen showed relatively higher eradication rate. CONCLUSIONS: Helicobacter pylori eradication rates of rifabutin- or levofloxacin-based triple therapy could not achieve enough eradication rate. Further studies would be needed on combination of levofloxacin and rifabutin-based regimen or culture based treatment.
Adult
;
Aged
;
Aged, 80 and over
;
Amoxicillin/therapeutic use
;
Anti-Bacterial Agents/*therapeutic use
;
Breath Tests
;
Drug Resistance, Bacterial/drug effects
;
Drug Therapy, Combination
;
Female
;
Helicobacter Infections/*drug therapy
;
Helicobacter pylori
;
Humans
;
Male
;
Middle Aged
;
Ofloxacin/*therapeutic use
;
Proton Pump Inhibitors/therapeutic use
;
Rifabutin/*therapeutic use
;
Salvage Therapy
10.Influencing Factors to Results of the Urease Test: Age, Sampling Site, Histopathologic Findings, and Density of Helicobacter pylori.
Ji Hyun SEO ; Hee Shang YOUN ; Jung Je PARK ; Jung Sook YEOM ; Ji Sook PARK ; Jin Su JUN ; Jae Young LIM ; Chan Hoo PARK ; Hyang Ok WOO ; Gyung Hyuck KO ; Seung Chul BAIK ; Woo Kon LEE ; Myung Je CHO ; Kwang Ho RHEE
Pediatric Gastroenterology, Hepatology & Nutrition 2013;16(1):34-40
PURPOSE: We investigated the positivity rate and the time period to the positive color change of the urease test in children and adults and assessed the correlation of the urease test to histopathologic findings. METHODS: From 1995 to 2000, endoscopic biopsies of the antrum and body were collected from 811 children and 224 adults and subjected to urease tests and histopathology. RESULTS: The positivity rate of the urease test was 49.4% for 0-4 years, 48.4% for 5-9 years, 47.3% for 10-15 years, and 62.5% for 20-29 years in the antrum. The positivity rate was 85.1% in 0-4 years, 82.3% in 5-9 years, 74.7% in 10-15 years, and 74.1% in 20-29 years for the body. In the antrum, the highest positivity rate was <1 hour for the group aged 10-29 years and 6-24 hours in the group <10 years old (p<0.0001). In the body, the highest positivity rate was <1 hour in adults and 6-24 hours in children (p<0.0001). The proportions of the positive reactions within 1 hour were similar for the antrum and the body. In the cases of more severe chronic gastritis, active gastritis, and Helicobacter pylori infiltration, a positive urease test reaction occurred more quickly (p<0.0001). CONCLUSION: There were significant differences in urease tests according to age and sampling site. The discrepancy between the antrum and the body was greater in younger children. These results might be related to the low density and patchy distribution of bacteria in children and in the body.
Adult
;
Aged
;
Bacteria
;
Biopsy
;
Child
;
Gastritis
;
Helicobacter
;
Helicobacter pylori
;
Humans
;
Urease